NCT06389058View on ClinicalTrials.gov

Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System

Active, not recruitingOBSERVATIONAL
Enrollment

31,795

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Severe Asthma
Interventions
OTHER

Recommendation for the diagnoses and treatment of Severe Asthma

No intervention planned in this phase for the patients. Recommendations to be developed for healthcare and condition.

Trial Locations (1)

92182-1309

San Diego State University, San Diego

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

Scripps Health

OTHER

collaborator

Modena Allergy + Asthma, La Jolla, CA

UNKNOWN

collaborator

University of California, San Diego

OTHER

lead

San Diego State University

OTHER

NCT06389058 - Using NLP and Neural Networks to Autonomously Identify Severe Asthma and Determine Study Eligibility in a Large Healthcare System | Biotech Hunter | Biotech Hunter